Flagship Pioneering, a leading creator of life sciences firms, said Wednesday it has raised $824 million in venture capital to bankroll startups, the Cambridge, Mass., company’s largest-ever single fundraising effort.

The infusion of cash comes 15 months after Flagship announced a $618 million fundraising round, its largest at the time. Since Flagship was founded in 2000, the venture capital firm has raised a total of $3.3 billion in eight funds to spawn and finance biotech, medical technology, and bio-agriculture businesses.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy